Leukemia chemotherapy Doctors Abroad — Page 3

Associate Professor Tahsin Ozatli specializes in treating breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at multiple oncology clinics
• Promoted to Associate Professor in 2016
• Studied at Selcuk University Faculty of Medicine

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Professor Hasan Atilla Ozkan brings extensive hematology expertise to VM Medical Park Pendik Hospital, specializing in leukemia chemotherapy.

• Over 23 years of experience of experience in hematology and bone marrow transplantation
• Current president of the Turkish Therapeutic Apheresis Association
• Trained in autologous and allogeneic stem cell transplantation
• Published researcher with a Young Investigator Award in apheresis

Dr. Alemdar specializes in leukemia chemotherapy with extensive training at Akdeniz University Hospital, a leading oncology center.

• Board-certified in medical oncology with over 20 years of experience of experience
• Worked at multiple prestigious hospitals including Akdeniz University Hospital
• Specialized in internal medicine before focusing on oncology

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Mahmoud M El Zembely heads the pediatric oncology department at Shefaa Al Orman Cancer Center. He is a specialist in pediatric oncology and malignant hematology. Dr. El Zembely completed a clinical fellowship in pediatric bone marrow transplantation at the Seattle Cancer Care Alliance. He treats various childhood cancers, including leukemia, lymphoma, and neuroblastoma.

• Manages all types of childhood leukemia and Hodgkin and non-Hodgkin lymphomas.
• Treats solid tumors such as nephroblastoma, rhabdomyosarcoma, and rare childhood cancers.
• Performs allogenic and autologous bone marrow transplantations for pediatric patients.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Danylesko specializes in leukemia chemotherapy at Sheba Medical Center, a leading oncology facility.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Professor Bosch is a globally recognized leader in Chronic Lymphocytic Leukemia (CLL), pioneering new treatments and technologies for hematological diseases.

• Over 126 years of experience of experience in hematology, specializing in lymphomas and CLL
• Leads clinical trials from phase 1 to phase 3, bringing new therapies to patients
• Head of Hematology at IOB Institute of Oncology and Vall d'Hebron University Hospital
• Published 100+ articles in top journals like The New England Journal of Medicine

Dr. Kim specializes in oncology and gynecology, offering expert care at Samsung Medical Center.

• Focuses on oncogynecological treatments
• Works at a top-tier medical facility
• Provides specialized care for complex cases

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Expert in personalized medicine and immuno-oncology
• Recipient of ASCO's MERIT award for lung cancer research
• Chair of IASLC's Early Detection & Prevention Committee
• Fellowship-trained at University of Colorado Denver

Prof. Myriam Ben Arush, an internationally recognized specialist in Pediatric Oncology, directs the Pediatric Division at Ruth Rappaport Children's Hospital.

• Recipient of the Ministry of Health Prize for outstanding work
• Awarded the Chevalier de la Legion d'Honneur in France
• Recognized as one of the world's most caring doctors by the World Medical Association
• Member of the children's oncology group in the USA and several European cancer societies